Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Monoclonal antibody treatment combo can reduce the impact of COVID-19 in high-risk patients

Monoclonal antibody treatment combo can reduce the impact of COVID-19 in high-risk patients

ACTG announces positive data for monoclonal antibody combination therapy from the ACTIV-2 study

ACTG announces positive data for monoclonal antibody combination therapy from the ACTIV-2 study

Persistence of Anti-PF4 levels in VITT patients four months after AstraZeneca COVID-19 vaccine

Persistence of Anti-PF4 levels in VITT patients four months after AstraZeneca COVID-19 vaccine

Hot spots where covid vaccination lags push experimental antibody treatment

Hot spots where covid vaccination lags push experimental antibody treatment

Non-invasive retinal imaging may be useful for detecting Alzheimer's disease risk

Non-invasive retinal imaging may be useful for detecting Alzheimer's disease risk

MHRA approves first monoclonal antibody treatment for COVID-19 in the UK

MHRA approves first monoclonal antibody treatment for COVID-19 in the UK

Cote d’Ivoire launches Ebola vaccination of first responders and health workers

Cote d’Ivoire launches Ebola vaccination of first responders and health workers

Data reinforces SAB-185’s potential to neutralize SARS-CoV-2 variants

Data reinforces SAB-185’s potential to neutralize SARS-CoV-2 variants

Camelid nanobody anti-SARS-CoV-2 drug candidates

Camelid nanobody anti-SARS-CoV-2 drug candidates

Small NIH clinical trial shows that new monoclonal antibody can prevent malaria

Small NIH clinical trial shows that new monoclonal antibody can prevent malaria

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

New insight into impact of SARS-CoV-2 mutations on receptor binding

New insight into impact of SARS-CoV-2 mutations on receptor binding

Aducanumab approval for Alzheimer's may provide a proof of concept that can be rapidly improved upon

Aducanumab approval for Alzheimer's may provide a proof of concept that can be rapidly improved upon

Combination therapy improves outcomes for relapsed chronic lymphocytic leukemia

Combination therapy improves outcomes for relapsed chronic lymphocytic leukemia

Monoclonal antibody could inform development of pan-coronavirus vaccines

Monoclonal antibody could inform development of pan-coronavirus vaccines

SARS-CoV-2 Q493R protein mutation shows resistance to monoclonal antibodies

SARS-CoV-2 Q493R protein mutation shows resistance to monoclonal antibodies

Spike-containing virus-like particles induce robust sterilizing immunity against SARS-CoV-2 in macaques

Spike-containing virus-like particles induce robust sterilizing immunity against SARS-CoV-2 in macaques

Impaired immune response to SARS-CoV-2 mRNA vaccination in immunocompromised patients

Impaired immune response to SARS-CoV-2 mRNA vaccination in immunocompromised patients

Monoclonal antibody CT-P59 demonstrates potent antiviral efficacy against SARS-CoV-2 delta variant

Monoclonal antibody CT-P59 demonstrates potent antiviral efficacy against SARS-CoV-2 delta variant

Synergistic multi-antibody cocktail protects against SARS-CoV-2 in animal model

Synergistic multi-antibody cocktail protects against SARS-CoV-2 in animal model

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.